Guardant Health, Inc. provided revenue guidance for full year 2023. For the period, the company expects revenue to be in the range of $553 to $556 million, representing growth of 23% to 24% compared to full year 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.51 USD | -4.50% | -14.21% | -16.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.78% | 2.75B | |
-26.90% | 9.98B | |
+26.20% | 2.87B | |
-17.50% | 2.07B | |
-24.25% | 1.59B | |
+64.58% | 1.43B | |
+31.92% | 824M | |
-5.02% | 733M | |
-29.59% | 508M | |
+0.20% | 296M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Revenue Guidance for Full Year 2023